Skip to main content
Oxford University Hospitals NHS Foundation Trust
Research and Development

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Medicines and Healthcare products Regulatory Agency (MHRA)

All studies falling into the category of Clinical Trials will require authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA).

The EU Clinical Trials Directive (EUCTD) is a legal document which sets out how clinical trials investigating the safety or efficacy of a medicinal product in humans must be conducted.

It was implemented into UK law in May 2004, as the Medicines for Human Use (Clinical Trials) Regulations 2004, and has since been amended (2006a, 2006b, 2008).

For details on making submissions to MHRA, and the fees, please visit: